Close menu




March 10th, 2023 | 10:20 CET

Cameco, GoviEx Uranium, Fission Uranium - Elemental energy source

  • Mining
  • Uranium
  • nuclear
  • Investments
Photo credits: pixabay.com

With the exception of Germany, the world's largest industrialized nations are focusing on expanding nuclear energy to achieve the climate targets they have set. However, due to the Ukraine conflict and possible sanctions against Russia, growing demand has been met with limited supply. The US alone obtains almost half of the uranium it needs from state-owned companies in Russia or Kazakhstan. But rising demand is meeting a supply that is too tight. The primary beneficiaries here are Western companies in production or close to it.

time to read: 3 minutes | Author: Stefan Feulner
ISIN: CAMECO CORP. | CA13321L1085 , GOVIEX URANIUM INC A | CA3837981057 , FISSION URANIUM CORP. | CA33812R1091

Table of contents:


    Nuclear energy as the key

    Germany aims to become greenhouse-neutral by 2045 and thus meet the global climate goal of limiting global warming to less than 2 degrees Celsius. This is to be achieved by accelerating the expansion of renewable energies to 100% in electricity generation and altogether abandoning fossil fuels. The share of nuclear power used to generate electricity in Germany was only 6.0% in the first half of 2022 and will be reduced to zero soon by the planned closure of the last three active nuclear reactors. In contrast, major industrialized countries such as Canada and the USA are focusing on constructing new, state-of-the-art reactors and subsidizing them massively. Canada has announced it will provide CAD 970 million to develop a grid-scale small modular reactor, which is being promoted as a key part of the country's plans to reduce emissions. Similarly, US President Joe Biden is supporting the uranium sector in the United States with a USD 4.3 billion plan to minimize dependence on Russia and address the energy crisis.

    Domestic businesses benefit

    The primary beneficiaries of the government programs are domestic uranium producers such as Cameco and Fission Uranium or exploration companies such as GoviEx Uranium that are about to start production. If there is an expected rebound in the uranium price, these, in particular, should perform with leverage over established producers. GoviEx is one of the largest uranium explorers on the African continent and is developing its flagship Madaouela project in Niger into the next producing mine. Niger is considered the fifth largest uranium producer globally and acted as the largest supplier of uranium oxide to the European continent in 2021. The government supports the domestic uranium industry tremendously, with a 20% interest in Madaouela. The project hosts one of the largest uranium resources in the world, with 100 million pounds of uranium oxide in measured and indicated mineral resources, plus inferred resources of 20 million pounds. Production is scheduled to begin in late 2025.

    Last year's feasibility study indicated a net present value, net of 8% tax, of USD 140 million at an internal rate of return of 13.3%. At a mining rate of 2.60 million pounds per year and an expected mine life of more than 20 years, there would be potential to produce 50.8 million pounds of uranium oxide.

    Start of production in the near future

    In addition, GoviEx has another iron in the fire with the fully permitted Muntanga project in Zambia. The feasibility study is expected in 2024. A pre-feasibility study in 2017 indicated a net present value of USD 177 million, net of 8% tax, with a mine life of 11 years. At Muntanga, a field program of 15,500m of infill drilling was undertaken to upgrade the project's Dibbwi East resource from the inferred to the indicated category. In addition, GoviEx commissioned 9,000m of diamond drilling to obtain core samples for uranium assays to be used for confirmatory metallurgical test work.

    On the other hand, the Falea uranium-silver-copper-gold project in Mali is to be sold. In order to focus on the two uranium-only properties, Madaouela and Muntanga, an agreement has been reached with African Energy Metals for the sale in a USD 5.5 million deal that will allow GoviEx to continue to retain a significant interest in the Falea project, as the payment includes a cash component as well as shares in African Energy Metals and a 3% NSR.

    GoviEX, a prospective uranium company, has a market capitalization of CAD 114.29 million. Measured against the peer group, the Canadians still have significant upside potential. Uranium producers are valued at around USD 6.86 per pound, while developers are valued at only USD 2.28 per pound. As the start of production draws nearer, this valuation gap should be increasingly eliminated.


    After a 10-year bear market, the uranium sector is at a turning point. The strong tailwinds reviving the nuclear industry are supported by aggressive climate targets, growing energy demand and major policy changes. In this regard, GoviEx Uranium is well-positioned with its two promising projects. An approaching start of production at Madaouela should offset the current undervaluation relative to the peer group.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    Stefan Feulner

    The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
    He is passionate about analyzing a wide variety of business models and investigating new trends.

    About the author



    Related comments:

    Commented by André Will-Laudien on June 29th, 2026 | 07:30 CEST

    AI and M&A Frenzy in the Life Sciences Sector: Bayer, Vidac Pharma, Novo Nordisk, Evotec, and Eli Lilly

    • Biotechnology
    • Pharma
    • Biotech
    • AI
    • Investments

    Yes, you read that correctly. Pharmaceutical companies are actively embracing artificial intelligence (AI) and, thanks to lower costs, better validation, and faster study setups, could emerge as winners of the new AI wave in the medium term. Many stocks in the life sciences sector had been overlooked by the market, but investors are now taking notice again. Eli Lilly is betting on AI and expanding its portfolio through targeted acquisitions, including the takeovers of sleep-wake specialist Centessa Pharmaceuticals and blood cancer specialist Ajax. At Evotec and Vidac Pharma, much of the focus is on cancer, while Novo Nordisk faces stiff competition from Eli Lilly's weight-loss drugs. Then came the welcome news regarding Bayer. The Supreme Court ruled that approximately 181,000 individual lawsuits alleging a lack of warning labels on packaging are no longer legally viable, as the US Environmental Protection Agency (EPA) has classified the herbicide glyphosate as safe. Lots of good news, and plenty of opportunities for active investors - we provide a few insights.

    Read

    Commented by Fabian Lorenz on June 29th, 2026 | 07:15 CEST

    Gold at USD 6,000! Analysts Turn Bullish! Lahontan Gold Stock Belongs in the Portfolio

    • Mining
    • Gold
    • Silver
    • Commodities
    • Nevada
    • geopolitics

    Will the falling oil price fuel a new rally in gold? In recent weeks, inflation fears and the associated concerns about rising interest rates have been among the key headwinds for precious metals. With the expected easing of geopolitical tensions in the Iran conflict, this pressure is now diminishing. Lower energy prices could ease inflation expectations, thereby reducing the likelihood of further rate hikes. Gold has recently defended the USD 4,000 per ounce level and even briefly traded above USD 4,300 on Wednesday. Gold expert Markus Bußler remains bullish, a view that should also support renewed strength in gold equities. Lahontan Gold is in an exciting phase. The company is currently transitioning from explorer to producer—not just anywhere, but in one of the world's most attractive gold mining regions. While preparations for mine construction are underway, the company continues to report positive drill results.

    Read

    Commented by André Will-Laudien on June 29th, 2026 | 07:10 CEST

    Gold, Defense, Aerospace: Sector Rotation in Full Swing – SpaceX, OHB, Desert Gold, Rheinmetall, and TKMS

    • Mining
    • Gold
    • Silver
    • Commodities
    • Africa
    • Defense
    • Steel
    • Space

    Stock markets remain surprisingly resilient as the end of June approaches, but the glossy surface is starting to fade in certain segments. The bull market in aerospace is losing steam, and in the defense sector, after many months of gains, profit-taking is now becoming noticeable. As a result, valuations are gradually re-aligning with fundamentals. For rational investors, market hype is difficult to reconcile with, but one thing remains clear: stocks that become excessively overvalued tend to correct sharply when expectations are pushed to extreme levels without sufficient justification. Just as with Elon Musk's inflated initial valuation, the exit bell has likely rung quite loudly for Rheinmetall as well. In the fall, analysts had been outbidding each other with price targets around EUR 2,200; now they are painfully backtracking. Price declines of 20% in just a few trading hours for the defence sector star, and a 30% drop from its peak for SpaceX. But there are other hot candidates worth a closer look. OHB is drawing attention following a significant capital increase, while TKMS has secured a major naval contract. These developments are actively reshaping market dynamics—we break down what it means in detail.

    Read